NASDAQ:RNTX | Insider Transactions — Page 2 | Rein Therapeutics, Inc.

RNTX Insider Transactions — Page 2

198 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–198; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Gregory KathrynSVP, Chief Business Officer2019-08-13Purchase45,000.0$0.65
NOVARTIS AGTenPercentOwner2019-04-01Sale20,610.0$1.9
Novartis Bioventures LtdTenPercentOwner2019-04-01Sale20,610.0$1.9
NOVARTIS AGTenPercentOwner2019-03-29Sale106,540.0$1.85
Novartis Bioventures LtdTenPercentOwner2019-03-29Sale106,540.0$1.85
NOVARTIS AGTenPercentOwner2019-03-15Sale43,800.0$1.92
Novartis Bioventures LtdTenPercentOwner2019-03-15Sale43,800.0$1.92
NOVARTIS AGTenPercentOwner2019-03-14Sale13,800.0$1.88
Novartis Bioventures LtdTenPercentOwner2019-03-14Sale13,800.0$1.88
NOVARTIS AGTenPercentOwner2019-03-13Sale132,738.0$2.12
Novartis Bioventures LtdTenPercentOwner2019-03-13Sale132,738.0$2.12
NOVARTIS AGTenPercentOwner2018-08-20Sale20,388.0$2.3
Novartis Bioventures LtdTenPercentOwner2018-08-20Sale20,388.0$2.3
NOVARTIS AGTenPercentOwner2018-08-17Sale8,700.0$2.1
Novartis Bioventures LtdTenPercentOwner2018-08-17Sale8,700.0$2.1
NOVARTIS AGTenPercentOwner2018-08-16Sale8,808.0$2.1
Novartis Bioventures LtdTenPercentOwner2018-08-16Sale8,808.0$2.1
NOVARTIS AGTenPercentOwner2018-08-15Sale2,635.0$2.15
Novartis Bioventures LtdTenPercentOwner2018-08-15Sale2,635.0$2.15
NOVARTIS AGTenPercentOwner2018-08-14Sale3,300.0$2.26
Novartis Bioventures LtdTenPercentOwner2018-08-14Sale3,300.0$2.26
NOVARTIS AGTenPercentOwner2018-08-13Sale1,600.0$2.36
Novartis Bioventures LtdTenPercentOwner2018-08-13Sale1,600.0$2.36
NOVARTIS AGTenPercentOwner2018-08-10Sale5,615.0$2.44
Novartis Bioventures LtdTenPercentOwner2018-08-10Sale5,615.0$2.44
LONGENECKER JOHN P PHDPresident and CEO2018-08-10Purchase10,000.0$2.45
NOVARTIS AGTenPercentOwner2018-08-09Sale235.0$2.48
Novartis Bioventures LtdTenPercentOwner2018-08-09Sale235.0$2.48
NOVARTIS AGTenPercentOwner2018-08-08Sale1,000.0$2.78
Novartis Bioventures LtdTenPercentOwner2018-08-08Sale1,000.0$2.78
NOVARTIS AGTenPercentOwner2018-08-07Sale1,739.0$2.97
Novartis Bioventures LtdTenPercentOwner2018-08-07Sale1,739.0$2.97
NOVARTIS AGTenPercentOwner2018-08-06Sale2,942.0$3.02
Novartis Bioventures LtdTenPercentOwner2018-08-06Sale2,942.0$3.02
NOVARTIS AGTenPercentOwner2018-08-02Sale4,702.0$3.33
Novartis Bioventures LtdTenPercentOwner2018-08-02Sale4,702.0$3.33
NOVARTIS AGTenPercentOwner2018-08-01Sale8,181.0$3.22
Novartis Bioventures LtdTenPercentOwner2018-08-01Sale8,181.0$3.22
NOVARTIS AGTenPercentOwner2018-07-31Sale4,500.0$3.07
Novartis Bioventures LtdTenPercentOwner2018-07-31Sale4,500.0$3.07
NOVARTIS AGTenPercentOwner2018-07-30Sale2,000.0$3.27
Novartis Bioventures LtdTenPercentOwner2018-07-30Sale2,000.0$3.27
NOVARTIS AGTenPercentOwner2018-07-27Sale6,458.0$3.38
Novartis Bioventures LtdTenPercentOwner2018-07-27Sale6,458.0$3.38
NOVARTIS AGTenPercentOwner2018-07-26Sale7,937.0$3.63
Novartis Bioventures LtdTenPercentOwner2018-07-26Sale7,937.0$3.63
NOVARTIS AGTenPercentOwner2018-07-25Sale12,460.0$3.84
Novartis Bioventures LtdTenPercentOwner2018-07-25Sale12,460.0$3.84
NOVARTIS AGTenPercentOwner2018-07-24Sale700.0$4.11
Novartis Bioventures LtdTenPercentOwner2018-07-24Sale700.0$4.11
NOVARTIS AGTenPercentOwner2018-07-23Sale30,600.0$4.25
Novartis Bioventures LtdTenPercentOwner2018-07-23Sale30,600.0$4.25
NOVARTIS AGTenPercentOwner2018-07-17Sale12,500.0$4.71
Novartis Bioventures LtdTenPercentOwner2018-07-17Sale12,500.0$4.71
NOVARTIS AGTenPercentOwner2018-07-16Sale300.0$5.15
Novartis Bioventures LtdTenPercentOwner2018-07-16Sale300.0$5.15
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-26Sale10,528.0$5.45
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-25Sale913.0$5.86
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-22Sale94,816.0$5.98
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-21Sale1,447.0$5.3
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-20Sale5,200.0$5.3
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-19Sale139.0$5.3
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-18Sale1,432.0$5.35
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-15Sale7,961.0$5.32
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-12Sale10,843.0$5.4
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-11Sale18,525.0$5.41
Dougherty DonaldSVP & Chief Financial Officer2018-06-08Purchase3,000.0$5.4
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-08Sale9,617.0$5.4
APPLE TREE PARTNERS II LPTenPercentOwner2018-06-07Sale20.0$5.48
Aivado ManuelSee Remarks2018-06-06Purchase1,000.0$5.61
Dougherty DonaldSVP & Chief Financial Officer2018-06-01Purchase2,000.0$5.24
APPLE TREE PARTNERS II LPTenPercentOwner2018-04-19Sale104,799.0$6.29
APPLE TREE PARTNERS II LPTenPercentOwner2018-04-17Sale3,105.0$7.05
APPLE TREE PARTNERS II LPTenPercentOwner2018-01-09Sale150,000.0$9.8
Kapnick ScottDirector,TenPercentOwner2017-07-05Purchase66,666.0$15.0
Shanafelt ArmenDirector2017-07-05Purchase250,000.0$15.0
Torres S. EdwardOther2017-07-05Purchase250,000.0$15.0
Lilly Ventures Fund I LLCOther2017-07-05Purchase250,000.0$15.0
Hall Steven EdwardOther2017-07-05Purchase250,000.0$15.0
LV Management Group, LLCOther2017-07-05Purchase250,000.0$15.0
AJU IB Investment Co., Ltd.TenPercentOwner2017-07-05Purchase24,929.0$15.0
Gallagher Brian M. Jr.Director2017-07-05Purchase273,333.0$15.0
Sigma Emerging Markets Ltd.TenPercentOwner2017-07-05Purchase190,000.0$15.0
EXCEL MEDICAL FUND LPTenPercentOwner2017-07-05Purchase60,000.0$15.0
Gullans Steven R. Ph.D.TenPercentOwner2017-07-05Purchase60,000.0$15.0
Excel Medical Ventures, LLCTenPercentOwner2017-07-05Purchase60,000.0$15.0
Blume Frederick R.TenPercentOwner2017-07-05Purchase60,000.0$15.0
Enriquez JuanTenPercentOwner2017-07-05Purchase60,000.0$15.0
Satter Muneer ATenPercentOwner2017-07-05Purchase33,333.0$15.0
KCK LTD.TenPercentOwner2017-07-05Purchase200,000.0$15.0
ROCHE HOLDING LTDTenPercentOwner2017-07-05Purchase119,400.0$15.0
ROCHE FINANCE LTDTenPercentOwner2017-07-05Purchase119,400.0$15.0
CVF, LLCTenPercentOwner2017-07-05Purchase180,000.0$15.0
Kapnick ScottDirector,TenPercentOwner2017-07-05Purchase66,666.0$15.0
Kapnick ScottDirector,TenPercentOwner2017-07-05Purchase159,307.0$15.0
Ambros Reinhard J.Director2017-07-05Purchase266,667.0$15.0
NOVARTIS AGTenPercentOwner2017-07-05Purchase266,667.0$15.0
Novartis Bioventures LtdTenPercentOwner2017-07-05Purchase266,667.0$15.0